Instil Bio (NASDAQ: TIL)
$37.50
(2.6%)
$0.94
Price as of June 12, 2025, 4:00 p.m. ET
Instil Bio Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Instil Bio Company Info
Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.
News & Analysis
Featured Article
Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher?
A candidate that Instil Bio in-licensed this August is similar to a candidate that recently outperformed the world's top-selling cancer therapy.
Cory Renauer | Sep 14, 2024
Featured Article
At a Recent Cancer Research Conference, Instil Bio Stole the Show
The clinical-stage cell therapy company reported impressive response rates for its candidate treatment against metastatic melanoma.
Patrick Bafuma | Apr 29, 2021
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.